Repeated course antenatal steroids, inflammation gene polymorphisms, and neurodevelopmental outcomes at age 2

Erin A S Clark1, Lisa Mele, Ronald J Wapner

  • 1Departments of Obstetrics and Gynecology at the University of Utah, Salt Lake City, UT 84132, USA. erin.clark@hsc.utah.edu

Insights

Repeated antenatal corticosteroids may mitigate neurodevelopmental delay risks linked to the IL-6 -174 GG genotype. This finding suggests a potential protective effect in infants with this genetic predisposition.

Area of Science:

  • Perinatology
  • Genetics
  • Neurodevelopmental Pediatrics

Background:

  • Antenatal corticosteroids are used to mature fetal lungs.
  • Repeated courses may increase risks for neurodevelopmental issues.
  • Inflammation gene polymorphisms are implicated in neurodevelopmental outcomes.

Purpose of the Study:

  • To investigate the interaction between repeated antenatal corticosteroid courses and inflammation gene polymorphisms.
  • To assess the impact on neurodevelopmental outcomes at 2 years of age.

Main Methods:

  • Nested case-control analysis within a randomized controlled trial.
  • Comparison of single vs. repeated antenatal corticosteroid courses.
  • Analysis of 4 inflammation gene polymorphisms in cases with neurodevelopmental delay versus controls.

Main Results:

  • A significant interaction was found between repeated corticosteroids and the interleukin (IL)-6 -174 genotype (P = .046).
  • The IL-6 -174 GG genotype was associated with increased neurodevelopmental delay risk in the single-course group (OR, 6.47).
  • Repeated antenatal corticosteroids abrogated this genotype-associated risk (OR, 1.30).

Conclusions:

  • Repeated-course antenatal steroids may reduce the risk of neurodevelopmental delay associated with the IL-6 -174 GG genotype.
  • This suggests a potential protective role of repeated antenatal corticosteroids in genetically susceptible infants.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Gene-Environment Interactions01:20

Gene-Environment Interactions

Gene expression is a dynamic process that is significantly influenced by environmental factors. This interaction underlies the complex nature of biological development and the phenotypic differences observed among individuals, even among those with identical genetic makeups. Factors such as radiation, temperature, behavior, nutrition, and stress play pivotal roles in determining how genes are expressed. The concept of the reaction range is central to understanding this interaction. It posits...
Behavioral Genetics and Its Designs01:23

Behavioral Genetics and Its Designs

Behavior genetics explores how genetic inheritance influences human behavior. It focuses on how genes, passed from parents to offspring, contribute to the development of behavioral traits and tendencies. This branch of genetics seeks to understand the complex interplay between inherited genetic factors and environmental influences in shaping our behaviors.
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...